Dna X annual capital expenditures (capex)
2018
2019
2020
2021
2022
2023
2024
Dna X Capital Expenditures (CapEx) Growth & History (SONM)
Dna X's capital expenditures (capex) was $214,000 for fiscal 2024.
View full Dna X company overviewDna X annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $214,000 | $178,000 | +494.44% |
| 2023 | 2023-12-31 | $36,000 | $28,000 | +350.00% |
| 2022 | 2022-12-31 | $8,000 | −$38,000 | −82.61% |
| 2021 | 2021-12-31 | $46,000 | $35,000 | +318.18% |
| 2020 | 2020-12-31 | $11,000 | −$981,000 | −98.89% |
| 2019 | 2019-12-31 | $992,000 | $205,000 | +26.05% |
| 2018 | 2018-12-31 | $787,000 | — | — |
Dna X quarterly capital expenditures (capex)
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $8,000 | — | — |
| Q3 2024 | 2024-09-30 | $137,000 | $136,000 | +13600.00% |
| Q2 2024 | 2024-06-30 | $39,000 | — | — |
| Q1 2024 | 2024-03-31 | $30,000 | — | — |
| Q3 2023 | 2023-09-30 | $1,000 | $1,000 | — |
| Q4 2022 | 2022-12-31 | $2,000 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q2 2022 | 2022-06-30 | $3,000 | — | — |
| Q1 2022 | 2022-03-31 | $3,000 | — | — |
| Q4 2020 | 2020-12-31 | $192,000 | $108,000 | +128.57% |
| Q3 2020 | 2020-09-30 | $10,000 | −$651,000 | −98.49% |
| Q2 2020 | 2020-06-30 | $9,000 | −$156,000 | −94.55% |
| Q1 2020 | 2020-03-31 | $184,000 | $102,000 | +124.39% |
| Q4 2019 | 2019-12-31 | $84,000 | −$201,000 | −70.53% |
| Q3 2019 | 2019-09-30 | $661,000 | $414,000 | +167.61% |
| Q2 2019 | 2019-06-30 | $165,000 | −$21,000 | −11.29% |
| Q1 2019 | 2019-03-31 | $82,000 | $13,000 | +18.84% |
| Q4 2018 | 2018-12-31 | $285,000 | — | — |
| Q3 2018 | 2018-09-30 | $247,000 | — | — |
| Q2 2018 | 2018-06-30 | $186,000 | — | — |
| Q1 2018 | 2018-03-31 | $69,000 | — | — |
Dna X capital expenditures (capex) trends
Over the last five fiscal years, Dna X's capital expenditures (capex) decreased from $992,000 to $214,000, a change of −$778,000. The latest reported quarter, Q4 2024, shows $8,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dna X source filings ↗